Inflammation  >>  oxelumab (RG4930)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxelumab (RG4930) / Roche, Genmab
NCT01152619: A Study of RO4989991 in Patients With Allergic Rhinitis

Completed
1
24
US
Placebo, RO4989991
Hoffmann-La Roche
Asthma
02/11
02/11

Download Options